HDAC9 and atherosclerosis: Moreover, in vitro histone deacetylase 9 (HDAC9) inhibition sustained EC marker expression and prevented mesenchymal transition, and HDAC9 KO in atherosclerosis-prone mice reduced plaque area, linking EndoMT to atherosclerosis progression (130).